PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

pantoprazole Side Effects

The reactions most often reported to the FDA for pantoprazole (also sold as Protonix), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

240,800
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2003 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of pantoprazole come from 240,800 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 240,800 reports to the FDA Adverse Event Reporting System (FAERS) for pantoprazole (Protonix): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

240,800

Reports Mentioning Death

27,099

11.3% of reports — not proof the medicine caused the death

Hospitalizations

111,504

46.3% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

FATIGUE
19,879
NAUSEA
16,988
DIARRHOEA
16,633
DYSPNOEA
16,592
PAIN
14,962
HEADACHE
12,661
VOMITING
12,157
ARTHRALGIA
11,725
ACUTE KIDNEY INJURY
11,212
PYREXIA
11,125
ASTHENIA
10,938
CHRONIC KIDNEY DISEASE
10,553
DIZZINESS
10,360
PNEUMONIA
10,146
RASH
10,116
CONDITION AGGRAVATED
8,736
MALAISE
8,639
PRURITUS
8,616

Who Reports Side Effects

Gender Distribution

Female 126,496 (58%)
Male 92,271 (42%)
Unknown 191

Age Distribution

0-17 2,427 (1%)
18-44 21,462 (13%)
45-64 57,494 (34%)
65-74 45,511 (27%)
75+ 44,438 (26%)

Reporting Trend by Year

2003 2025

Reactions in Death Reports

Top reactions reported in 27,099 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 8,323
PNEUMONIA 2,343
GENERAL PHYSICAL HEALTH DETERIORATION 2,285
DYSPNOEA 2,148
DIARRHOEA 2,131
FATIGUE 2,130
VOMITING 1,931
PYREXIA 1,776
ASTHENIA 1,773
NAUSEA 1,748
ACUTE KIDNEY INJURY 1,726
PAIN 1,693
HYPERTENSION 1,613
RASH 1,584
CONDITION AGGRAVATED 1,560
CONFUSIONAL STATE 1,501
DECREASED APPETITE 1,497
HEADACHE 1,444
ARTHRALGIA 1,431

Reactions in Hospitalization Reports

Top reactions in 111,504 reports where hospitalization was an outcome.

Reaction Reports
DYSPNOEA 9,997
NAUSEA 8,886
FATIGUE 8,686
DIARRHOEA 8,583
PNEUMONIA 7,629
VOMITING 7,598
PYREXIA 7,404
PAIN 6,616
ASTHENIA 6,614
GENERAL PHYSICAL HEALTH DETERIORATION 6,182
FALL 5,878
ANAEMIA 5,539
HEADACHE 5,467
ACUTE KIDNEY INJURY 5,453
DIZZINESS 5,316
ARTHRALGIA 4,987
ABDOMINAL PAIN 4,983
CONDITION AGGRAVATED 4,976

Compare pantoprazole vs alosetron →

What the FAERS Data Reveals About pantoprazole Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 240,800 voluntary reports linked to pantoprazole and its brand equivalents (Protonix), spanning 2003 through 2025. Of those, 27,099 (11.3%) listed death as an outcome and 111,504 (46.3%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 58% were female and 42% male; age distribution skews toward 45-64, with 57,494 reports in that bracket. The single most reported reaction is fatigue with 19,879 submissions, followed by nausea and diarrhoea.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.